2018 Reoxygenation Injury Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Reoxygenation Injury Market

June 2018 | 70 pages | ID: 23631FF12E1EN
VPAResearch

Abstracts

Reoxygenation Injury is a heart related condition in which blood supply is restored to the tissue after some period of ischemia or absence of oxygen supply. The new supply causes additional complications such as inflammation, innate immunity, and oxidative stress instead of restoring regular function.

To assist researchers, investors and business development managers, VPA Research has come up with a comprehensive report on Reoxygenation Injury pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Reoxygenation Injury pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Reoxygenation Injury pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.

Contents

1 TABLE OF CONTENTS

1.1 List of LIST OF FIGURES
1.2 List of Tables

2 REOXYGENATION INJURY PIPELINE ANALYSIS

2.1 Disease and Pipeline Overview
2.2 Reoxygenation Injury Pipeline Snapshot
2.3 Reoxygenation Injury Pipeline by Phase
2.4 Reoxygenation Injury Pipeline by Company
2.5 Reoxygenation Injury Pipeline by Mechanism of Action

3 REOXYGENATION INJURY- COMPANY WISE PIPELINE ANALYSIS

Angion Biomedica Corp
Armaron Bio Pty Ltd
BioMedCore Inc
Bolder Biotechnology Inc
Catalyst Biosciences Inc
Celdara Medical LLC
CFM Pharma Holding BV
Corline Biomedical AB
Faraday Pharmaceuticals
Glucox Biotech AB
Ischemix Inc
MallInckrodt Plc
Miragen Therapeutics Inc
NovelMed Therapeutics Inc
Opsona Therapeutics Ltd
Pharming Group NV
Prolong Pharmaceuticals LLC
Prothix BV
Radikal Therapeutics Inc
SBI Pharmaceuticals Co Ltd
TheraSource LLC
TRIM-edicine Inc
X-In8 Biologicals Corp
List Continues….

4 REOXYGENATION INJURY R&D PIPELINE SNAPSHOTS

Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/ License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details

5 RECENT DEVELOPMENTS IN REOXYGENATION INJURY PIPELINE

6 APPENDIX

6.1 About VPA Research
6.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Reoxygenation Injury Pipeline by Phase, H2- 2018
Figure 2: Reoxygenation Injury Pipeline by Companies, H2- 2018
Figure 3: Company Wise Pipeline Drug Phases, H2- 2018
Figure 4: Reoxygenation Injury Pipeline by Mechanism of Action, H2- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H2- 2018

List Of Tables

LIST OF TABLES

Reoxygenation Injury Pipeline by Phase, H2- 2018
Reoxygenation Injury Pipeline by Companies, H2- 2018
Reoxygenation Injury Pipeline by Mechanism of Action, H2- 2018
Table 1: Angion Biomedica Corp Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 2: Armaron Bio Pty Ltd Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 3: BioMedCore Inc Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 4: Bolder Biotechnology Inc Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 5: Catalyst Biosciences Inc Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 6: Celdara Medical LLC Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 7: CFM Pharma Holding BV Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 8: Corline Biomedical AB Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 9: Faraday Pharmaceuticals Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 10: Glucox Biotech AB Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 11: Ischemix Inc Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 12: MallInckrodt Plc Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 13: Miragen Therapeutics Inc Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 14: NovelMed Therapeutics Inc Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 15: Opsona Therapeutics Ltd Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 16: Pharming Group NV Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 17: Prolong Pharmaceuticals LLC Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 18: Prothix BV Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 19: Radikal Therapeutics Inc Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 20: SBI Pharmaceuticals Co Ltd Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 21: TheraSource LLC Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 22: TRIM-edicine Inc Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 23: X-In8 Biologicals Corp Reoxygenation Injury Pipeline Drugs, H2- 2018
Table 24: List Continues…. Reoxygenation Injury Pipeline Drugs, H2- 2018